Healthcare Services

CRISPR Gene Editing Market Future Outlook Showing Expansion Toward $8.28 Billion by 2030

March 31, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The CRISPR Gene Editing Market During 2026–2030?

The crispr gene editing market size has experienced significant expansion in recent years. It is anticipated to grow from $2.88 billion in 2025 to $3.65 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 27.1%. This historical growth can be attributed to the demand for precise gene modification tools, the limitations of older gene editing technologies, the advancement of genomics research, its adoption in academic settings, and funding allocated to genetic research.

The crispr gene editing market is poised for substantial expansion in the coming years. It is forecast to grow to $8.28 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 22.7%. This anticipated growth is attributed to the approval of gene editing therapies, the broadening scope of precision medicine, progress in agricultural biotechnology, the development of regulatory frameworks, and ongoing technological enhancements of crispr systems. Noteworthy trends during this forecast period include the surge in clinical gene therapy research, the increased application of agricultural gene editing, the proliferation of functional genomics studies, advancements in delivery technologies, and a greater emphasis on ethical and regulatory compliance.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15549&type=smp

Which Economic Or Industry Drivers Are Impacting The CRISPR Gene Editing Market?

The expanding occurrence of genetic disorders is projected to stimulate the advancement of the CRISPR gene editing market. A genetic disorder represents a health condition resulting from abnormalities in the genome, encompassing mutations within a single gene (monogenic), multiple genes (polygenic), or chromosomal irregularities. The rise in genetic disorder prevalence is attributed to genetic mutations, an aging global population, and consanguineous marriages. CRISPR gene editing provides substantial assistance in handling genetic disorders by enabling precise and targeted modifications to an individual’s DNA. Furthermore, researchers utilize CRISPR technology to pinpoint and rectify specific mutations that cause genetic disorders, thereby restoring normal biological functions and mitigating disease symptoms, as observed in conditions such as cystic fibrosis and sickle cell anaemia. For instance, in October 2025, as reported by the Cystic Fibrosis Trust, a UK-based charity supporting individuals with cystic fibrosis, the year 2024 saw 164 new diagnoses of cystic fibrosis (CF), with 123 of these cases identified via newborn screening. By the close of 2024, a total of 11,381 individuals were registered with CF. Consequently, the growing prevalence of genetic disorders is fueling the expansion of the CRISPR gene editing market.

How Are The Various Segments Of The CRISPR Gene Editing Market Categorized?

The crispr gene editing market covered in this report is segmented –

1) By Type: CRISPR-Associated Nuclease (Cas Nuclease), Guide Ribonucleic Acid (RNA), Deoxyribonucleic Acid (DNA) Ligase, Restriction Endonuclease, Other Types

2) By Services: Design Tools, Plasmid And Vector, CRISPR-Associated Protein 9 (Cas9) And Guide Ribonucleic Acid (g-RNA), Delivery System Products, Other Services

3) By Technology: CRISPR Or Cas9, Zinc Finger Nucleases, Other Technologies

4) By Application: Agricultural, Biomedical, Industrial, Genome Engineering, Disease Models, Functional Genomics, Other Applications

5) By End User: Academic Institutes And Research Centers, Biotechnology Companies, Contract Research Organizations (CROs), Pharmaceutical And Biopharmaceutical Companies

Subsegments:

1) By CRISPR-Associated Nuclease (Cas Nuclease): Cas9, Cas12, Cas13

2) By Guide Ribonucleic Acid (RNA): Single-Guide RNA (sgRNA), Dual-Guide RNA, Synthetic Guide RNA

3) By Deoxyribonucleic Acid (DNA) Ligase: T4 DNA Ligase, E. Coli DNA Ligase

4) By Restriction Endonuclease: Type II Restriction Enzymes, Type I And III Restriction Enzymes

5) By Other Types: CRISPR Delivery Systems, CRISPR Plasmids, CRISPR-Based Diagnostic Tools

What Trends Are Affecting The Expansion Of The CRISPR Gene Editing Market?

Major entities within the CRISPR gene editing market are focusing on developing innovative products, such as gene therapy, to attract broader customer bases, increase sales, and boost revenue. Gene therapy is a medical method that uses genes to treat, prevent, or cure various diseases and disorders. For example, in December 2023, the US Food and Drug Administration (FDA), a federal agency based in the US, approved Casgevy, a cell-based gene therapy, for the management of sickle cell disease. Casgevy therapy operates by utilizing CRISPR/Cas9, a particular type of genome editing technology. Specifically, hematopoietic stem cells are modified through the application of CRISPR/Cas9 technology.

Which Major Firms Influence Developments In The CRISPR Gene Editing Market?

Major companies operating in the crispr gene editing market are Crispr Therapeutics, Thermo Fisher Scientific, Intellia Therapeutics, Horizon Discovery, Synthego Corporation, Integrated DNA Technology (Danaher), Editas Medicine, GenScript, Agilent Technologies, New England Biolabs, CSIR-Institute of Genomics & Integrative Biology (IGIB), Strand Life Sciences Pvt. Ltd., Bio Palette Co. Ltd., Churchi Genome Engineering and Therapeutic Research Center, Beam Therapeutics Inc., Eurofins Genomics India, Setsurotech Co. Ltd., Merck Japan, Institut Pasteur, CureVac, Cellectis, BiovelocITA S.r.l., Evotec A.G., SNIPR Biome, Oxford Genetics, ERS Genomics, Alia Therapeutics, Solvo, BioTalentum, BIOCAD, BioVendor, Research & Diagnostic Products, Contipro, Lonza Biotec, Sotio, Selvita, BioVentures Institute Ltd, Sigma-Aldrich, Poseida Therapeutics, NanoCellect Biomedical, Sherlock Biosciences, Repare Therapeutics, Inscripta Inc., Santa Cruz Biotechnology, Caribou Biosciences Inc., Egenesis Inc., Homology Medicines, System Biosciences, Takara Bio USA Inc., Inari Agriculture Inc., Precision BioSciences, Cell Microsystems Inc., GeneCopoeia Inc., Merck KGaA, Origene Technologies Inc., Pluristem Therapeutics Inc.

Read the full crispr gene editing market report here:

https://www.thebusinessresearchcompany.com/report/crispr-gene-editing-global-market-report

What Are The Top-Performing Regions Within The CRISPR Gene Editing Market?

North America was the largest region in the CRISPR gene editing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the crispr gene editing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored CRISPR Gene Editing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15549&type=smp

Browse Through More Reports Similar to the Global CRISPR Gene Editing Market 2026, By The Business Research Company

Crispr Gene Editing Global Market Report

https://www.thebusinessresearchcompany.com/report/crispr-gene-editing-global-market-report

Crispr Technology Market

https://www.thebusinessresearchcompany.com/report/crispr-technology-market

Plant Breeding And Crispr Plants Global Market Report

https://www.thebusinessresearchcompany.com/report/plant-breeding-and-crispr-plants-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795